test bank for
pharmacotherapeutics for advanced practice nurse
prescribers fifth edition
by teri moser woo & marylou v. robinson( all chapters
covered 1-55 with answer section)
,
,table of contents
chapter 1. the role of the nurse practitioner ................................................................................................ 5
chapter 2. review of basic principles of pharmacology ................................................................................ 6
chapter 3. rational drug selection ............................................................................................................... 16
chapter 4. legal and professional issues in prescribing .............................................................................. 19
chapter 5. adverse drug reactions .............................................................................................................. 22
chapter 6. pharmacoeconomics ................................................................................................................. 26
chapter 7. nutrition and nutraceuticals ...................................................................................................... 29
chapter 8. herbal therapy and nutritional supplements ............................................................................ 38
chapter 9. informatics ................................................................................................................................. 42
chapter 10. pharmacoeconomics ............................................................................................................... 46
chapter 11. drugs affecting the autonomic nervous system ...................................................................... 49
chapter 12. drugs affecting the central nervous system ............................................................................ 60
chapter 13. drugs affecting the cardiovascular and renal systems ............................................................ 70
chapter 14. drugs affecting the respiratory system.................................................................................... 80
chapter 15. drugs affecting the hematological system .............................................................................. 86
chapter 16. drugs affecting the immune system ........................................................................................ 91
chapter 17. drugs affecting the gastrointestinal system ............................................................................ 96
chapter 18. drugs affecting the endocrine system: pancreatic hormones and antidiabetic drugs ............ 99
chapter 19. drugs affecting the endocrine system: pituitary, thyroid, and adrenal drugs....................... 106
chapter 20. drugs affecting the reproductive system............................................................................... 120
chapter 21. drugs affecting the bones and joints ..................................................................................... 126
chapter 22. drugs affecting the integumentary system ........................................................................... 134
chapter 23. drugs used in treating bacterial diseases .............................................................................. 140
chapter 24. drugs used to treat viral, fungal, and protozoal infections ................................................... 146
chapter 25. drugs used in treating inflammatory processes .................................................................... 153
chapter 26. drugs used in treating eye and ear disorders ........................................................................ 157
chapter 27. alcohol and drug addiction .................................................................................................... 160
chapter 28. anemia ................................................................................................................................... 166
chapter 29. angina .................................................................................................................................... 170
chapter 30. anxiety and depression.......................................................................................................... 175
chapter 31. attention deficit hyperactivity disorder................................................................................. 180
chapter 32. asthma and chronic obstructive pulmonary disease ............................................................. 183
,chapter 33. contraception ........................................................................................................................ 187
chapter 34. dermatologic conditions ........................................................................................................ 190
chapter 35. diabetes management ........................................................................................................... 194
chapter 36. gastroesophageal reflux and peptic ulcer disease ................................................................ 204
chapter 37. headaches .............................................................................................................................. 208
chapter 38. heart failure ........................................................................................................................... 212
chapter 39. human immunodeficiency virus disease and acquired immunodeficiency .......................... 217
chapter 40. hormone replacement therapy ............................................................................................. 221
chapter 41. hyperlipidemia ....................................................................................................................... 226
chapter 42. hypertension.......................................................................................................................... 231
chapter 43. hyperthyroidism and hypothyroidism ................................................................................... 236
chapter 44. pain management: acute and chronic pain ........................................................................... 240
chapter 45. pneumonia............................................................................................................................. 244
chapter 46. smoking cessation ................................................................................................................. 247
chapter 47. sexually transmitted infections and vaginitis ........................................................................ 250
chapter 48. tuberculosis ........................................................................................................................... 255
chapter 49. upper respiratory infection, pharyngitis, sinusitis, otitis media, and otitis externa ............. 258
chapter 50. urinary tract infections .......................................................................................................... 261
chapter 51: women as patients ................................................................................................................ 264
chapter 52. men as patients ..................................................................................................................... 269
chapter 53. pediatric patients ................................................................................................................... 271
chapter 54. transgendered clients as patients ......................................................................................... 274
chapter 55. geriatric patients.................................................................................................................... 278
,chapter 1. the role of the nurse practitioner
multiple choice
identify the choice that best completes the statement or answers the question.
1. nurse practitioner prescriptive authority is regulated by:
1. the national council of state boards of nursing
2. the u.s. drug enforcement administration
3. the state board of nursing for each state
4. the state board of pharmacy
2. the benefits to the patient of having an advanced practice registered nurse (aprn) prescriber
include:
1. nurses know more about pharmacology than other prescribers because they take it both in their
basic nursing program and in their aprn program.
2. nurses care for the patient from a holistic approach and include the patient in decision making
regarding their care.
3. aprns are less likely to prescribe narcotics and other controlled substances.
4. aprns are able to prescribe independently in all states, whereas a physician’s assistant needs to
have a physician supervising their practice.
3. clinical judgment in prescribing includes:
1. factoring in the cost to the patient of the medication prescribed
2. always prescribing the newest medication available for the disease process
3. handing out drug samples to poor patients
4. prescribing all generic medications to cut costs
4. criteria for choosing an effective drug for a disorder include:
1. asking the patient what drug they think would work best for them
2. consulting nationally recognized guidelines for disease management
3. prescribing medications that are available as samples before writing a prescription
4. following u.s. drug enforcement administration guidelines for prescribing
,5. nurse practitioner practice may thrive under health-care reform because of:
1. the demonstrated ability of nurse practitioners to control costs and improve patient outcomes
2. the fact that nurse practitioners will be able to practice independently
3. the fact that nurse practitioners will have full reimbursement under health-care reform
4. the ability to shift accountability for medicaid to the state level
chapter 1. the role of the nurse practitioner answer section
multiple choice
1ANSWER> 3 pts: 1
2ANSWER> 2 pts: 1
3ANSWER> 1 pts:1
4ANSWER> 2 pts: 1
5. ans: 1 pts: 1
chapter 2. review of basic principles of pharmacology
multiple choice
identify the choice that best completes the statement or answers the question.
1. a patient’s nutritional intake and laboratory results reflect hypoalbuminemia. this is critical to
prescribing because:
, 1. distribution of drugs to target tissue may be affected.
2. the solubility of the drug will not match the site of absorption.
3. there will be less free drug available to generate an effect.
4. drugs bound to albumin are readily excreted by the kidneys.
2. drugs that have a significant first-pass effect:
1. must be given by the enteral (oral) route only
2. bypass the hepatic circulation
3. are rapidly metabolized by the liver and may have little if any desired action
4. are converted by the liver to more active and fat-soluble forms
3. the route of excretion of a volatile drug will likely be the:
1. kidneys
2. lungs
3. bile and feces
4. skin
4. medroxyprogesterone (depo provera) is prescribed intramuscularly (im) to create a storage
reservoir of the drug. storage reservoirs:
1. assure that the drug will reach its intended target tissue
2. are the reason for giving loading doses
3. increase the length of time a drug is available and active
4. are most common in collagen tissues
5. the np chooses to give cephalexin every 8 hours based on knowledge of the drug’s:
1. propensity to go to the target receptor
2. biological half-life
3. pharmacodynamics
4. safety and side effects
6. azithromycin dosing requires that the first day’s dosage be twice those of the other 4 days of the
prescription. this is considered a loading dose. a loading dose:
1. rapidly achieves drug levels in the therapeutic range
2. requires four- to five-half-lives to attain
pharmacotherapeutics for advanced practice nurse
prescribers fifth edition
by teri moser woo & marylou v. robinson( all chapters
covered 1-55 with answer section)
,
,table of contents
chapter 1. the role of the nurse practitioner ................................................................................................ 5
chapter 2. review of basic principles of pharmacology ................................................................................ 6
chapter 3. rational drug selection ............................................................................................................... 16
chapter 4. legal and professional issues in prescribing .............................................................................. 19
chapter 5. adverse drug reactions .............................................................................................................. 22
chapter 6. pharmacoeconomics ................................................................................................................. 26
chapter 7. nutrition and nutraceuticals ...................................................................................................... 29
chapter 8. herbal therapy and nutritional supplements ............................................................................ 38
chapter 9. informatics ................................................................................................................................. 42
chapter 10. pharmacoeconomics ............................................................................................................... 46
chapter 11. drugs affecting the autonomic nervous system ...................................................................... 49
chapter 12. drugs affecting the central nervous system ............................................................................ 60
chapter 13. drugs affecting the cardiovascular and renal systems ............................................................ 70
chapter 14. drugs affecting the respiratory system.................................................................................... 80
chapter 15. drugs affecting the hematological system .............................................................................. 86
chapter 16. drugs affecting the immune system ........................................................................................ 91
chapter 17. drugs affecting the gastrointestinal system ............................................................................ 96
chapter 18. drugs affecting the endocrine system: pancreatic hormones and antidiabetic drugs ............ 99
chapter 19. drugs affecting the endocrine system: pituitary, thyroid, and adrenal drugs....................... 106
chapter 20. drugs affecting the reproductive system............................................................................... 120
chapter 21. drugs affecting the bones and joints ..................................................................................... 126
chapter 22. drugs affecting the integumentary system ........................................................................... 134
chapter 23. drugs used in treating bacterial diseases .............................................................................. 140
chapter 24. drugs used to treat viral, fungal, and protozoal infections ................................................... 146
chapter 25. drugs used in treating inflammatory processes .................................................................... 153
chapter 26. drugs used in treating eye and ear disorders ........................................................................ 157
chapter 27. alcohol and drug addiction .................................................................................................... 160
chapter 28. anemia ................................................................................................................................... 166
chapter 29. angina .................................................................................................................................... 170
chapter 30. anxiety and depression.......................................................................................................... 175
chapter 31. attention deficit hyperactivity disorder................................................................................. 180
chapter 32. asthma and chronic obstructive pulmonary disease ............................................................. 183
,chapter 33. contraception ........................................................................................................................ 187
chapter 34. dermatologic conditions ........................................................................................................ 190
chapter 35. diabetes management ........................................................................................................... 194
chapter 36. gastroesophageal reflux and peptic ulcer disease ................................................................ 204
chapter 37. headaches .............................................................................................................................. 208
chapter 38. heart failure ........................................................................................................................... 212
chapter 39. human immunodeficiency virus disease and acquired immunodeficiency .......................... 217
chapter 40. hormone replacement therapy ............................................................................................. 221
chapter 41. hyperlipidemia ....................................................................................................................... 226
chapter 42. hypertension.......................................................................................................................... 231
chapter 43. hyperthyroidism and hypothyroidism ................................................................................... 236
chapter 44. pain management: acute and chronic pain ........................................................................... 240
chapter 45. pneumonia............................................................................................................................. 244
chapter 46. smoking cessation ................................................................................................................. 247
chapter 47. sexually transmitted infections and vaginitis ........................................................................ 250
chapter 48. tuberculosis ........................................................................................................................... 255
chapter 49. upper respiratory infection, pharyngitis, sinusitis, otitis media, and otitis externa ............. 258
chapter 50. urinary tract infections .......................................................................................................... 261
chapter 51: women as patients ................................................................................................................ 264
chapter 52. men as patients ..................................................................................................................... 269
chapter 53. pediatric patients ................................................................................................................... 271
chapter 54. transgendered clients as patients ......................................................................................... 274
chapter 55. geriatric patients.................................................................................................................... 278
,chapter 1. the role of the nurse practitioner
multiple choice
identify the choice that best completes the statement or answers the question.
1. nurse practitioner prescriptive authority is regulated by:
1. the national council of state boards of nursing
2. the u.s. drug enforcement administration
3. the state board of nursing for each state
4. the state board of pharmacy
2. the benefits to the patient of having an advanced practice registered nurse (aprn) prescriber
include:
1. nurses know more about pharmacology than other prescribers because they take it both in their
basic nursing program and in their aprn program.
2. nurses care for the patient from a holistic approach and include the patient in decision making
regarding their care.
3. aprns are less likely to prescribe narcotics and other controlled substances.
4. aprns are able to prescribe independently in all states, whereas a physician’s assistant needs to
have a physician supervising their practice.
3. clinical judgment in prescribing includes:
1. factoring in the cost to the patient of the medication prescribed
2. always prescribing the newest medication available for the disease process
3. handing out drug samples to poor patients
4. prescribing all generic medications to cut costs
4. criteria for choosing an effective drug for a disorder include:
1. asking the patient what drug they think would work best for them
2. consulting nationally recognized guidelines for disease management
3. prescribing medications that are available as samples before writing a prescription
4. following u.s. drug enforcement administration guidelines for prescribing
,5. nurse practitioner practice may thrive under health-care reform because of:
1. the demonstrated ability of nurse practitioners to control costs and improve patient outcomes
2. the fact that nurse practitioners will be able to practice independently
3. the fact that nurse practitioners will have full reimbursement under health-care reform
4. the ability to shift accountability for medicaid to the state level
chapter 1. the role of the nurse practitioner answer section
multiple choice
1ANSWER> 3 pts: 1
2ANSWER> 2 pts: 1
3ANSWER> 1 pts:1
4ANSWER> 2 pts: 1
5. ans: 1 pts: 1
chapter 2. review of basic principles of pharmacology
multiple choice
identify the choice that best completes the statement or answers the question.
1. a patient’s nutritional intake and laboratory results reflect hypoalbuminemia. this is critical to
prescribing because:
, 1. distribution of drugs to target tissue may be affected.
2. the solubility of the drug will not match the site of absorption.
3. there will be less free drug available to generate an effect.
4. drugs bound to albumin are readily excreted by the kidneys.
2. drugs that have a significant first-pass effect:
1. must be given by the enteral (oral) route only
2. bypass the hepatic circulation
3. are rapidly metabolized by the liver and may have little if any desired action
4. are converted by the liver to more active and fat-soluble forms
3. the route of excretion of a volatile drug will likely be the:
1. kidneys
2. lungs
3. bile and feces
4. skin
4. medroxyprogesterone (depo provera) is prescribed intramuscularly (im) to create a storage
reservoir of the drug. storage reservoirs:
1. assure that the drug will reach its intended target tissue
2. are the reason for giving loading doses
3. increase the length of time a drug is available and active
4. are most common in collagen tissues
5. the np chooses to give cephalexin every 8 hours based on knowledge of the drug’s:
1. propensity to go to the target receptor
2. biological half-life
3. pharmacodynamics
4. safety and side effects
6. azithromycin dosing requires that the first day’s dosage be twice those of the other 4 days of the
prescription. this is considered a loading dose. a loading dose:
1. rapidly achieves drug levels in the therapeutic range
2. requires four- to five-half-lives to attain
